Kentucky Women's Justice Community Overdose Innovation Network - Phase II
Michele Staton · with National Institute on Drug Abuse (NIDA) · NCT07179614
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 300
- US sites recruiting
- 3
- Study start
- June 23, 2026
- Record last updated
- September 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impact regarding the effectiveness, implementation, and sustainability of innovative overdose prevention strategies during the high-risk time of community re-entry among vulnerable, CLS-involved women in rural communities. This research will impact the field by increasing the capacity of the criminal legal system to respond to the overdose crisis through increased access to prevention strategies to reduce overdose risk.
Being studied: Overdose Prevention Intervention Package (OPIP)
Conditions: Overdose Risk; Opioid Use Disorder; Stimulant Use Disorders
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- DSM-5 scores of 2+ for opioids (OUD) and/or stimulants (StUD),
- no evidence of cognitive impairment in providing consent,
- a release date within 7-60 days to allow for time for intervention sessions,
- willingness to consider SUD treatment post-release, and
- willingness to provide the name and contact information of at least one person in the community who will support the woman's recovery pre/post-release (SP).
Exclusion Criteria
- Not living in a rural area
- Any condition that would not allow capable informed consent
Recruiting US locations
Knox County Detention Center
Barbourville, KY 40906
Site contact: Mary Hammons, Jailer · 606-546-6215 · mailto:jailer01@barbourville.com
Harlan County Detention Center
Harlan, KY 40828
Site contact: Derrick Moore Deputy Jailer · 606-837-0096 · HarlanDep@ky.gov
Leslie County Detention Center
Hyden, KY 41749
Site contact: Danny Clark, Jailer · 606-672-1167 · dannyclark.lcdc@outlook.com
Study contacts (from the official record)
- Michele Staton, PhD · 859-312-8245 · mstaton@uky.edu
- Martha Tillson, PhD · 859-447-5007 · martha.tillson@uky.edu
Similar studies in Kentucky
All healthy volunteers studies in Kentucky →- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Louisville, KY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Louisville, KY + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Gilead Sciences
- Location
- Louisville, KY + 4 other US sites
- Eligibility basics
- Ages 18–69
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Louisville, KY + 18 other US sites
- Eligibility basics
- Ages 18–100